GRML (Greenland Mines) Short Interest


GRML Greenland Mines Ltd GRML
12 GF Score
Price $0.25
! 1 Warning Sign
View Full Analysis

What is Greenland Mines Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

GRML vs SRGZ, RITE, DYNR: Short Interest Comparison

For the Other Precious Metals & Mining subindustry, Greenland Mines's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Greenland Mines Short Interest vs Metals & Mining Industry

For the Metals & Mining industry and Basic Materials sector, Greenland Mines's Short Interest distribution charts can be found below:

* The bar in red indicates where Greenland Mines's Short Interest falls into.


GRML
12GF Score
Greenland Mines Ltd GRML
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Greenland Mines Business Description

Address 1300 South Boulevard, Unit D, Charlotte, NC, USA, 28203
Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases - cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.
12GF Score

Get the complete analysis for GRML

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.25
Price